Abstract:OBJECTIVE:The aim of this study was to measure the impact of zero-mark-up drug policy (ZMDP) on drug-related expenditures and use in urban hospitals.DESIGN:This was a retrospective observational study of trends in drug expenses and use in the context of the ZMDP using an interrupted time series analysis.SETTING:Twelve hospitals (three tertiary hospitals and nine secondary hospitals) in Xi'an, which is the capital of Shaanxi Province in Western China.DATA AND PARTICIPANTS:The prescription information for all outpatients and inpatients in the study hospitals from January 2016 to April 2018 was used in this study.INTERVENTIONS:The Chinese government announced the policy intervention measure of the ZMDP, which was implemented in all public hospitals as of 1 April 2017.PRIMARY MEASURES:Monthly drug expenditures, monthly medical expenditures, the percentage of drug expenditures among total medical expenditures, the average outpatient drug expenditure per visit, the percentage of prescriptions that include an injection and the percentage of prescriptions that include an antibiotic.RESULTS:Monthly total medical expenses increased in both tertiary and secondary hospitals after the ZMDP was implemented. In tertiary hospitals, the average outpatient drug expenditures per visit showed a slow decreasing trend before the intervention and an increasing trend after the intervention, with statistically significant changes in both the level (p<0.001) and the trend (p=0.02). Secondary hospitals showed a slow increasing trend both before and after the policy implementation, with no significant change in the trend (p=0.205). The proportion of prescriptions, including injections, was over 20% in secondary hospitals and less than 20% in tertiary hospitals, with no significant changes to this indicator observed after implementation of ZMDP.CONCLUSIONS:The effect of the ZMDP on drug-related expenditures and use in Chinese public hospitals was not substantially evident. Future pharmaceutical reform measures should give more consideration to physician prescription behaviours.

Patients hardly benefit from drug price reduction and hospital following higher price drugs:An analysis on penicillin prescriptions from 2000 to 2008 in Shanghai

Patients can hardly benefit from the government's drug price reduction policies: analysis of hospitals'cephalosporin using during top 100 medical prescription drugs from 2000 to 2008 in Shanghai Take cephalosporin drugs as an example

Analysis on the Trend of Drug Use in 22 Hospitals in Hangzhou Region During the Period from 2002 to 2004

Impact on Hospital Medicine After Adjusting the Drug Pricing Method

Can Price Controls Reduce Pharmaceutical Expenses? A Case Study Of Antibacterial Expenditures In 12 Chinese Hospitals From 1996 To 2005

Is the prescribing behavior of Chinese physicians driven by financial incentives?

Study of the Antibacterials Purchase Price Trends from 1996 to 2005 of Beijing Sample Hospitals

Effects of Different Mark-Up Drug Policies on Drug-Related Expenditures in Tertiary Public Hospitals: an Interrupted Time Series Study in Shanghai, China, 2015-2018.

医院“以药养医”不改变，药品降价措施效果难以惠及患者：以医院头孢类药品使用为例

An Analysis on Rational Use and Affordability of Medicine after the Implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China

Differential effect of China's Zero Markup Drug Policy on provider-induced demand in secondary and tertiary hospitals

The Effect of the Implementation of Low Price Medicine Policy on Medicine Price in China: A Retrospective Study

Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study

Analysis on the structure of drug expenditure in Shanghai municipal

The Situation of Drugs Used in the Hospitals of Shanghai District During the Period of 2000-2002

The study on zero profit drug supply and the corresponding reimbursement policy in medical institutions in Shanghai

The Situation of Drugs Used in the Hospitals of Shanghai District During the Period of 1999-2001

Preliminary analysis of pharmaceuticals zero mark-up policy in Shanghai

Intended and Unintended Impacts of Price Changes for Drugs and Medical Services: Evidence from China.

Exploring the new way to reduce medicine price by negotiation between government and pharmaceutical factory

Impact of the Zero-Mark-up Drug Policy on Drug-Related Expenditures and Use in Public Hospitals, 2016–2018: an Interrupted Time Series Study in Shaanxi